← Research Library

Tier 2 · Peer-reviewed secondaryreviewmoderate

The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism

Veech RL · 2004 · Prostaglandins, Leukotrienes and Essential Fatty Acids

DOI: 10.1016/j.plefa.2003.09.007View source ↗

Mild ketosis may offer therapeutic potential in a variety of different common and rare disease states.

Summary

Richard Veech's 2004 review is the most-cited mechanistic argument that ketone bodies — specifically D-β-hydroxybutyrate — are not just an alternative fuel but a more efficient one in metabolic terms. Veech's central claim is that the enthalpy of D-β-hydroxybutyrate combustion is higher per unit oxygen consumed than glucose, meaning more ATP per oxygen molecule. He uses this thermodynamic observation to argue that mild ketosis may be therapeutically useful in conditions where mitochondrial efficiency is compromised: insulin resistance, neurodegeneration, ischemia, and certain rare metabolic disorders. The review covers redox state changes during ketosis (favorable shifts in NAD+/NADH), the role of free fatty acid elevation alongside ketones in ketogenic-diet states, and the activation of PPAR signaling. Veech's framing seeded the modern field of "exogenous ketones as therapy" and is widely cited in research on ketogenic diets for epilepsy, Alzheimer's disease, and traumatic brain injury. The therapeutic claims are speculative for many of the listed conditions; the underlying biochemistry is rigorous.

Talking it through with practitioners

The Inner Circle is a paid, async-first community for discussing what new evidence means for actual cycles — opening soon.

Join the waitlist →

Citation graph

How this entry connects to the rest of the library

References cited by this entry

Entries that reference this one

  • ExtendsBrain metabolism during fastingOwen OE et al. · 1967

    Veech 2004 builds on the brain-ketone-uptake biology characterized first by Owen and colleagues, extending it into the βHB-as-signaling-molecule literature.

Tags

Not medical advice. This page summarizes primary research. It is not a substitute for consultation with a qualified clinician. See safety for exclusion criteria.